Painkiller form may matter after gastric bypass
NCT ID NCT06658574
First seen Jul 06, 2026 · Last updated Aug 25, 2026 · Updated 3 times
Summary
This study tests whether liquid or pill acetaminophen works better for pain after gastric bypass or sleeve gastrectomy. Surgery changes how the stomach absorbs medication, so the form of the drug could affect pain relief. Adults who had one of these procedures will receive either liquid or tablet acetaminophen, and their pain scores and opioid use will be compared.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acetaminophen (paracetamol)
- What this could lead to
- If one form works better, it could improve pain management after weight-loss surgery and reduce the need for stronger painkillers.
- What could go wrong
- This is a small, early-phase study. The results may not apply to all patients, and individual pain responses vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
65 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years old or greater who meet patient selection criteria for either primary Roux-en-Y gastric bypass or primary laparoscopic sleeve gastrectomy. Exclusion Criteria: * Patients with a known hypersensitivity or history of intolerance to acetaminophen or any inactive ingredients in either formulation. Patients uncomfortable with or unable to take pills. * Surgical: Duodenal Switch (DS) surgeries, Adjustable Gastric Banding (AGB), surgical revisions, and surgical conversions. * Medical: patients with documented history of chronic and/or current pain syndrome, as evidenced by documentation of ICD-10 code G89.4, patients with documented ICD-10 code F11.90, indication unspecified, uncomplicated opioid use. * Patients of vulnerable populations, as outlined by federal guidelines as children, prisoners, pregnant women, and mentally disabled persons will be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bariatric surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08690, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Can adding tramadol to spinal anesthesia extend pain relief after leg surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can cooking classes curb dangerous pregnancy weight gain?